Angiotensin I-converting enzyme genotype significantly affects progression of IgA glomerulonephritis in an Italian population

American Journal of Kidney Diseases

Volumn 33, Issue 6, 1999, Pages 1071-1079

  Stratta, P ^a   Canavese, C ^a   Ciccone, G ^a   Barolo, S ^a   Dall'Omo, A M ^a   Fasano, M E ^a   Mazzola, G ^a   Berutti, S ^a   Fop, F ^a   Curtoni, E S ^a   Piccoli, G ^a  

^a MOLINETTE HOSPITAL   (Italy)

Author keywords

Angiotensin I converting enzyme; Gene polymorphism; IgA nephropathy; Renal failure

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN A;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ENZYME ACTIVITY; FEMALE; GENOTYPE; GLOMERULONEPHRITIS; HEMODIALYSIS; HUMAN; IMMUNOGLOBULIN DEPOSITION; ITALY; KIDNEY FAILURE; MALE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE;

EID: 0033044915     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70144-7     Document Type: Article

References (58)

1. VE Andreucci M Gallieni D Brancaccio ACE inhibitors and progression of chronic renal insufficiency: A contribution of Italian clinical research J Nephrol 11 1998 105 109
2. B Rigat C Hubert F Alheno-Gelas F Lambien P Corvol F Soubrier An insertion/deletion polymorphism in the angiotensin 1-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 86 1990 1343 1346
3. O Costerousse J Allegrini M Lopez F Alheno-Gelas Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes Biochem J 290 1993 33 40
4. P Roy-Chaudhury ACE genotype and progression of IgA nephropathy Lancet 346 1995 571 572
5. KA Munger A Fogo G Nassar KF Badr A protective role for nitric oxide in the acute neutrophil dependent phase of nephrotoxic nephritis in rats J Am Soc Nephrol 5 1994 580 592
6. RJ Johnson CE Alpers A Yoshimura D Lombardi P Pritzl U Floege SM Schwartz Renal injury from angiotensin II–mediated hypertension Hypertension 19 1992 464 474
7. S Anderson HG Rennke BM Brenner Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat J Clin Invest 77 1986 1993 2000
8. Y Kakimuma T Khawamura T Bills T Yoshioka I Ichikawa A Fogo Blood pressure independent effect of angiotensin inhibition on the glomerular and non-glomerular vascular lesions of chronic renal failure Kidney Int 421 1992 46 55
9. EJ Lewis LG Hunsicker RP Bain RD Rohe The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy N Engl J Med 329 1993 1456 1462
10. DC Cattran C Greenwood S Ritchie Long-term benefit of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin A nephropathy: A comparison in patients receiving treatment with other antihypertensive agents and to patients receiving no therapy Am J Kidney Dis 29 1994 247 254
11. H Yoshida V Kon I Ichikawa Polymorphism of the renin-angiotensin system genes in progressive renal disease Kidney Int 50 1996 732 744
12. H Kitamura T Moriyama M Izumi K Yokoyama A Yamauchi N Ueda T Kamada E Imai Angiotensin I-converting enzyme insertion/deletion polymorphysm: Potential significance in nephrology Kidney Int 49 suppl 55 1996 S101 S103
13. H Yoshida Y Kuriyama Atsumi H Tomonari T Mitarai A Hamagughi H Kubo Y Kawaguchi V Kon K Matsuoka I Ichikawa O Sakai Angiotensin I-converting enzyme gene polymorphism in non–insulin-dependent diabetes mellitus Kidney Int 50 1996 657 664
14. S Schmidt K Strojek W Grzeszczak K Bergis E Ritz Excess of DD homozygotes in hemodialysed patients with type II diabetes. The Diabetic Nephropathy Study Group Nephrol Dial Transplant 12 1997 427 429
15. E Alamartine J Sabatier C Guerin JM Berliet F Berthoux Prognostic factor in mesangial IgA glomerulonephritis: An extensive study with univariate and multivariate analysis Am J Kidney Dis 18 1991 12 19
16. E Petersson IgA nephropathy: 30 Years On J Intern Med 242 1997 349 353
17. PN Harden C Geddes PA Rowe JH Mcllroy M Boulton-Jones RSC Rodger BJR Junor JD Briggs JMC Connell AG Jardine Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy Lancet 345 1995 1540 1542
18. T Yorioka T Suehiro N Yasuoka K Hashimoto M Kawada Polymorphism of the angiotensin-converting enzyme gene and clinical aspects of IgA nephropathy Clin Nephrol 44 1995 80 85
19. H Yoshida T Mitarai T Kawamura T Kitajma Y Miyazaki R Nagasawa Y Kawaguchi H Kubo I Ichikawa O Sakai Role of the deletion polymorphism of the angiotensin-converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy J Clin Invest 96 1995 2162 2169
20. TE Hunley BA Julian JA Phillips III ML Summar H Yoshida RG Horn NJ Brown A Fogo I Ichikawa V Kon Angiotensin-converting enzyme gene polymorphism. Potential silencer motif and impact on progression in IgA nephropathy Kidney Int 49 1996 571 577
21. T Fukushima S Nomura S Kawai G Osawa ACE genotype and progression of IgA nephropathy [letter] Lancet 346 1995 571
22. T Schmidt E Stier R Hartung G Stein J Bahnisch AJ Woodroffe AR Clarkson C Ponticelli M Campese G Mayer D Ganten E Ritz No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis Am J Kidney Dis 26 1995 727 731
23. M Burg J Menne T Ostendorf V Kliem J Floege Gene polymorphism of angiotensin-converting enzyme and endothelial nitric oxide synthase in patients with primary glomerulonephritis Clin Nephrol 18 1997 205 211
24. Y Pei J Scholey K Thai M Suzuki D Cattran Association of angiotensinogen gene T235 variant with progression of immunoglobulin A nephropathy in Caucasian patients J Clin Invest 100 1997 814 820
25. GH Galla IgA nephropathy Kidney Int 47 1995 377 387
26. P Freese G Norden G Nyberg Morphologic risk factors in IgA nephropathy Nephron 79 1998 420 425
27. B Rigatt C Hubert P Corvoll F Soubrier PCR detection of the insertion/deletion polymorphism of the human angiotensin-converting enzyme gene (DCP1) dipeptidil carboxipeptidase 1 Nucleic Acids Res 20 1992 1433A (abstr)
28. K Lindpaintner MA Pfeffer R Creutz MJ Stampfer F Grodstein F Lamotte J Buring H Hennekens A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and risk of ischemic heart disease N Engl J Med 332 1995 706 711
29. T Fujisawa H Ikegami Y Kawaguchi Y Yamada H Ueda M Shintani M Fukuda T Ogihara Meta-analysis of association of insertion/deletion polymorphism of angiotensin I converting enzyme with diabetic nephropathy and retinopathy Diabetologia 41 1998 47 53
30. R Kunz JP Bork L Fritsche J Ringel AM Sharma Association between the angiotensin-converting enzyme insertion/deletion polymorphism and diabetic nephropathy: A methodologic appraisal and systematic review J Am Soc Nephrol 9 1998 1653 1663
31. S Schmidt E Ritz The role of angiotensin I converting enzyme gene polymorphism in renal disease Curr Opin Nephrol Hypertens 5 1996 552 555
32. S Schmidt E Ritz Genetics of the renin-angiotensin system and renal disease: A progress report Curr Opin Nephrol Hypertens 6 1997 146 151
33. MV Raynolds MR Bristow EW Bush WT Abraham BD Lowes LS Zisman CS Taff MB Perryman Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomiopathy Lancet 342 1993 1073 1075
34. L Tiret A Bonnardeaux O Poirier S Ricard P Marques-Vidal A Evans D Arveiler G Luc F Kee P Ducimetiere F Soubrier F Cambien Synergistic effects of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphism on risk of myocardial infarction Lancet 344 1994 910 913
35. A Gardemann T Weiss O Schwartz A Eberbach N Katz FW Herlein H Tillmanns W Waas W Haberbosch Gene polymorphism but not catalytic activity of angiotensin I converting enzyme is associated with coronary artery disease and myocardial infarction in low-risk patients Circulation 92 1995 2796 2799
36. BR Winkelmann M Nauck B Klein AP Russ BO Bohn R Siekmeier K Ihnken M Verho W Gross W Marz Deletion polymorphism of the angiotensin I converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease Ann Intern Med 125 1996 19 25
37. NJ Samany JR Thompson L O'Tool K Channer KL Woods A meta-analysis of the association of the deletion allele of angiotensin converting enzyme gene with myocardial infarction Circulation 94 1996 708 712
38. HH Sigusch S Vogt U Gruber D Reinhardt K Lang R Surber K Farker S Muller A Hoffmann Angiotensin-I converting enzyme DD genotype is a risk factor of coronary artery disease Scand J Clin Lab Invest 57 1997 127 132
39. F Ribichini G Steffenino A Dellavalle G Matullo E Colajanni T Camilla A Vado G Benetton E Uslenghi A Piazza Plasma activity and insertion/deletion polymorphism of angiotensin I converting enzyme: A major risk factor and a marker of risk for coronary stent restenosis Circulation 97 1998 147 154
40. P Sharma Meta-analysis of the ACE gene in ischaemic stroke J Neurol Neurosurg Psychiatry 64 1998 227 230
41. E Ritz M Koch Morbidity and mortality due to hypertension in patients with renal failure Am J Kidney Dis 21 suppl 2 1993 S113 S118
42. H Nomura I Koni M Yasukatsu T Morise R Takeda Angiotensin-converting enzyme gene polymorphism in haemodialysis patients Lancet 343 1994 482 483
43. LJ Bloem AK Manatunga JH Pratt Racial difference in the relationship of angiotensin-converting enzyme gene polymorphism to serum angiotensin I converting enzyme activity Hypertension 27 1996 62 66
44. A Gardemann M Fink J Stricker QD Nguyen J Humme N Kats H Tillmanns FW Hehrlein M Rau W Haberbosch ACE I/D gene polymorphism: Presence of the ACE D allele increases the risk of coronary artery disease in younger individuals Atherosclerosis 139 1998 153 159
45. JL Anderson JF Carlquist GJ King L Morrison MJ Thomson EH Ludwig JB Muhlestein TL Bair RH Ward Angiotensin-converting enzyme genotypes and risk for myocardial infarction in women J Am Coll Cardiol 31 1998 790 796
46. K Hibi T Ishigami K Kimura M Nakao T Iwamoto K Tamura T Nemoto T Shimizu Y Mochida H Ochiai S Umemura M Ishii Angiotensin-converting enzyme gene polymorphism adds risk for the severity of coronary atherosclerosis in smokers Hypertension 30 1997 574 579
47. JP O'Malley CL Maslen DR Illingworth Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia Circulation 97 1998 1780 1783
48. P Schena A retrospective analysis of the natural history of primary IgA nephropathy worldwide Am J Med 89 1990 209 215
49. D Roccatello M Ferro R Coppo G Giraudo G Quattrocchio G Piccoli Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy Nephrol Dial Transplant 10 1995 2054 2059
50. G D'Amico Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy, and membranoproliferative glomerulonephritis: Survey of the recent literature Am J Kidney Dis 20 1992 315 323
51. R Coppo A Amore B Gianoglio MD Picciotto D Roccatello PG Fillipi Angiotensin I local hyperactivity in the progression of IgA nephropathy Am J Kidney Dis 21 1993 593 598
52. X Chen S Lin Y Ye Q Xu Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with the clinico-pathological manifestations in immunoglobulin A nephropathy patients Clin Med J 110 1997 526 529
53. R Tanaka K Iijima R Murakami M Koide H Nakamura N Yoshikawa ACE gene polymorphism in childhood IgA nephropathy: Association with clinico-pathological findings Am J Kidney Dis 31 1998 774 779
54. GG Van Essen PL Rensma D de Zeeuw WJ Sluiter H Scheffer AJ Apperloo PE de Jong Association between angiotensin-converting enzyme gene polymorphism and failure of renoprotective therapy Lancet 347 1996 94 95
55. S Mizuiri H Hemmi A Inove M Takano S Kadomatsu H Tanimoto M Tanegashima I Hayashy T Fushimi A Hasegawa Renal haemodynamic changes induced by captopril and angiotensin-converting enzyme gene polymorphism Nephron 75 1997 310 314
56. M Haas N Yilmaz A Schmidt U Neyer K Arnetz HK Stummvoll M Wallner M Avinger I Arias B Schneider G Mayer Angiotensin-converting enzyme gene polymorphism determines the antiproteinuric and systemic hemodynamic effect of enalapril in patients with proteinuric renal disease. Austrian Study Group of the Effects of Enalapril Treatment in Proteinuric Renal Disease Kidney Blood Press Res 21 1998 66 69
57. ON Harden KPJ O'Kane S Veda JMC Connell AG Jandine Association studies, ACE polymorphism and renal disease Nephrol Dial Transplant 11 1996 757 778
58. D Nvis PE De Jong D de Zeeuw I/D polymorphism of the angiotensin-converting enzyme gene: A clue to the heterogeneity in the progression of renal disease and in the renal response to therapy? Nephrol Dial Transplant 12 1997 1097 1100